These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 22946564

  • 1. Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential.
    Masunaga S, Liu Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K.
    Int J Hyperthermia; 2012; 28(7):636-44. PubMed ID: 22946564
    [Abstract] [Full Text] [Related]

  • 2. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
    Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K.
    Int J Radiat Biol; 2019 Dec; 95(12):1708-1717. PubMed ID: 31545117
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Dec; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H.
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [Abstract] [Full Text] [Related]

  • 6. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
    Masunaga S, Sakurai Y, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Nagasawa H, Uto Y, Hori H, Ono K.
    Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
    Masunaga S, Tano K, Watanabe M, Kashino G, Suzuki M, Kinashi Y, Ono K, Nakamura J.
    Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
    [Abstract] [Full Text] [Related]

  • 8. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K.
    Int J Hyperthermia; 2007 Feb; 23(1):29-35. PubMed ID: 17575721
    [Abstract] [Full Text] [Related]

  • 9. Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
    Masunaga S, Matsumoto Y, Kashino G, Hirayama R, Liu Y, Tanaka H, Sakurai Y, Suzuki M, Kinashi Y, Maruhashi A, Ono K.
    Br J Radiol; 2010 Sep; 83(993):776-84. PubMed ID: 20739345
    [Abstract] [Full Text] [Related]

  • 10. Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.
    Masunaga S, Liu Y, Tanaka H, Sakurai Y, Suzuki M, Kondo N, Maruhashi A, Ono K.
    Br J Radiol; 2011 Dec; 84(1008):1131-8. PubMed ID: 21586505
    [Abstract] [Full Text] [Related]

  • 11. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
    Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Liu Y, Kondo N, Maruhashi A, Kinashi Y, Ono K.
    Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
    [Abstract] [Full Text] [Related]

  • 12. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.
    Masunaga SI, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Tano K, Maruhashi A, Ono K.
    World J Oncol; 2013 Feb 01; 4(1):26-36. PubMed ID: 29147327
    [Abstract] [Full Text] [Related]

  • 14. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Ohnishi K, Takahashi A, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Oncol Rep; 2005 Aug 01; 14(2):393-400. PubMed ID: 16012721
    [Abstract] [Full Text] [Related]

  • 15. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1999 Aug 01; 17(4):259-64. PubMed ID: 10510897
    [Abstract] [Full Text] [Related]

  • 16. Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.
    Masunaga S, Matsumoto Y, Hirayama R, Kashino G, Tanaka H, Suzuki M, Kinashi Y, Liu Y, Ando K, Ono K.
    Clin Exp Metastasis; 2009 Aug 01; 26(7):693-700. PubMed ID: 19466568
    [Abstract] [Full Text] [Related]

  • 17. Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.
    Masunaga SI, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A, Ono K.
    World J Oncol; 2014 Aug 01; 5(4):155-165. PubMed ID: 29147396
    [Abstract] [Full Text] [Related]

  • 18. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
    Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Br J Radiol; 2000 Sep 01; 73(873):978-86. PubMed ID: 11064652
    [Abstract] [Full Text] [Related]

  • 19. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Int J Hyperthermia; 2006 Jun 01; 22(4):287-99. PubMed ID: 16754350
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y.
    Jpn J Cancer Res; 2000 May 01; 91(5):566-72. PubMed ID: 10835503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.